Literature DB >> 22794259

Network organization of the huntingtin proteomic interactome in mammalian brain.

Dyna I Shirasaki1, Erin R Greiner, Ismael Al-Ramahi, Michelle Gray, Pinmanee Boontheung, Daniel H Geschwind, Juan Botas, Giovanni Coppola, Steve Horvath, Joseph A Loo, X William Yang.   

Abstract

We used affinity-purification mass spectrometry to identify 747 candidate proteins that are complexed with Huntingtin (Htt) in distinct brain regions and ages in Huntington's disease (HD) and wild-type mouse brains. To gain a systems-level view of the Htt interactome, we applied Weighted Correlation Network Analysis to the entire proteomic data set to unveil a verifiable rank of Htt-correlated proteins and a network of Htt-interacting protein modules, with each module highlighting distinct aspects of Htt biology. Importantly, the Htt-containing module is highly enriched with proteins involved in 14-3-3 signaling, microtubule-based transport, and proteostasis. Top-ranked proteins in this module were validated as Htt interactors and genetic modifiers in an HD Drosophila model. Our study provides a compendium of spatiotemporal Htt-interacting proteins in the mammalian brain and presents an approach for analyzing proteomic interactome data sets to build in vivo protein networks in complex tissues, such as the brain.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22794259      PMCID: PMC3432264          DOI: 10.1016/j.neuron.2012.05.024

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  63 in total

1.  SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis.

Authors:  Ruth Luthi-Carter; David M Taylor; Judit Pallos; Emmanuel Lambert; Allison Amore; Alex Parker; Hilary Moffitt; Donna L Smith; Heike Runne; Ozgun Gokce; Alexandre Kuhn; Zhongmin Xiang; Michele M Maxwell; Steven A Reeves; Gillian P Bates; Christian Neri; Leslie M Thompson; J Lawrence Marsh; Aleksey G Kazantsev
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-08       Impact factor: 11.205

2.  Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG.

Authors:  S M Hersch; S Gevorkian; K Marder; C Moskowitz; A Feigin; M Cox; P Como; C Zimmerman; M Lin; L Zhang; A M Ulug; M F Beal; W Matson; M Bogdanov; E Ebbel; A Zaleta; Y Kaneko; B Jenkins; N Hevelone; H Zhang; H Yu; D Schoenfeld; R Ferrante; H D Rosas
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

3.  A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.

Authors:  Janghoo Lim; Tong Hao; Chad Shaw; Akash J Patel; Gábor Szabó; Jean-François Rual; C Joseph Fisk; Ning Li; Alex Smolyar; David E Hill; Albert-László Barabási; Marc Vidal; Huda Y Zoghbi
Journal:  Cell       Date:  2006-05-19       Impact factor: 41.582

4.  Shotgun proteomics in neuroscience.

Authors:  Lujian Liao; Daniel B McClatchy; John R Yates
Journal:  Neuron       Date:  2009-07-16       Impact factor: 17.173

5.  Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease.

Authors:  Judit Pallos; Laszlo Bodai; Tamas Lukacsovich; Judith M Purcell; Joan S Steffan; Leslie Michels Thompson; J Lawrence Marsh
Journal:  Hum Mol Genet       Date:  2008-09-01       Impact factor: 6.150

6.  Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling.

Authors:  Michael B Major; Nathan D Camp; Jason D Berndt; Xianhua Yi; Seth J Goldenberg; Charlotte Hubbert; Travis L Biechele; Anne-Claude Gingras; Ning Zheng; Michael J Maccoss; Stephane Angers; Randall T Moon
Journal:  Science       Date:  2007-05-18       Impact factor: 47.728

7.  Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models.

Authors:  Liliana Menalled; Bassem F El-Khodor; Monica Patry; Mayte Suárez-Fariñas; Samantha J Orenstein; Benjamin Zahasky; Christina Leahy; Vanessa Wheeler; X William Yang; Marcy MacDonald; A Jennifer Morton; Gill Bates; Janet Leeds; Larry Park; David Howland; Ethan Signer; Allan Tobin; Daniela Brunner
Journal:  Neurobiol Dis       Date:  2009-05-21       Impact factor: 5.996

8.  Huntingtin interacting proteins are genetic modifiers of neurodegeneration.

Authors:  Linda S Kaltenbach; Eliana Romero; Robert R Becklin; Rakesh Chettier; Russell Bell; Amit Phansalkar; Andrew Strand; Cameron Torcassi; Justin Savage; Anthony Hurlburt; Guang-Ho Cha; Lubna Ukani; Cindy Lou Chepanoske; Yuejun Zhen; Sudhir Sahasrabudhe; James Olson; Cornelia Kurschner; Lisa M Ellerby; John M Peltier; Juan Botas; Robert E Hughes
Journal:  PLoS Genet       Date:  2007-05-11       Impact factor: 5.917

9.  A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging.

Authors:  Jeremy A Miller; Michael C Oldham; Daniel H Geschwind
Journal:  J Neurosci       Date:  2008-02-06       Impact factor: 6.167

10.  Multiple pathways contribute to the pathogenesis of Huntington disease.

Authors:  Shihua Li; Xiao-Jiang Li
Journal:  Mol Neurodegener       Date:  2006-12-16       Impact factor: 14.195

View more
  128 in total

Review 1.  Huntington's Disease and Mitochondria.

Authors:  Mohammad Jodeiri Farshbaf; Kamran Ghaedi
Journal:  Neurotox Res       Date:  2017-06-21       Impact factor: 3.911

2.  Huntington's disease: easing the NMDAR traffic jam.

Authors:  Anthony Daggett; X William Yang
Journal:  Nat Med       Date:  2013-08       Impact factor: 53.440

3.  A large scale Huntingtin protein interaction network implicates Rho GTPase signaling pathways in Huntington disease.

Authors:  Cendrine Tourette; Biao Li; Russell Bell; Shannon O'Hare; Linda S Kaltenbach; Sean D Mooney; Robert E Hughes
Journal:  J Biol Chem       Date:  2014-01-09       Impact factor: 5.157

4.  Activation of Caspase-6 Is Promoted by a Mutant Huntingtin Fragment and Blocked by an Allosteric Inhibitor Compound.

Authors:  Dagmar E Ehrnhoefer; Niels H Skotte; Jeanette Reinshagen; Xiaofan Qiu; Björn Windshügel; Priyadarshini Jaishankar; Safia Ladha; Olga Petina; Mehdi Khankischpur; Yen T N Nguyen; Nicholas S Caron; Adelia Razeto; Matthias Meyer Zu Rheda; Yu Deng; Khuong T Huynh; Ilka Wittig; Philip Gribbon; Adam R Renslo; Detlef Geffken; Sheraz Gul; Michael R Hayden
Journal:  Cell Chem Biol       Date:  2019-07-25       Impact factor: 8.116

Review 5.  Exploring genetic modifiers of Gaucher disease: The next horizon.

Authors:  Brad A Davidson; Shahzeb Hassan; Eric Joshua Garcia; Nahid Tayebi; Ellen Sidransky
Journal:  Hum Mutat       Date:  2018-09-11       Impact factor: 4.878

Review 6.  Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder.

Authors:  Andrew J Levine; Stella E Panos; Steve Horvath
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

7.  A toxic mutant huntingtin species is resistant to selective autophagy.

Authors:  Yuhua Fu; Peng Wu; Yuyin Pan; Xiaoli Sun; Huiya Yang; Marian Difiglia; Boxun Lu
Journal:  Nat Chem Biol       Date:  2017-09-04       Impact factor: 15.040

Review 8.  Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.

Authors:  Sara D Reis; Brígida R Pinho; Jorge M A Oliveira
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

9.  Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis.

Authors:  Guohao Wang; Xudong Liu; Marta A Gaertig; Shihua Li; Xiao-Jiang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-07       Impact factor: 11.205

10.  Identification of NUB1 as a suppressor of mutant Huntington toxicity via enhanced protein clearance.

Authors:  Boxun Lu; Ismael Al-Ramahi; Antonio Valencia; Qiong Wang; Frada Berenshteyn; Haidi Yang; Tatiana Gallego-Flores; Salah Ichcho; Arnaud Lacoste; Marc Hild; Marian Difiglia; Juan Botas; James Palacino
Journal:  Nat Neurosci       Date:  2013-03-24       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.